Devyser Diagnostics AB (DVYSR) — Cash Flow-to-Debt Ratio
Devyser Diagnostics AB (DVYSR) has a Cash Flow-to-Debt Ratio of 0.11x as of March 2026, meaning its operating cash flow of Skr12.10 Million could theoretically repay 0% of its total liabilities (Skr112.20 Million) in one year. See how much free cash does Devyser Diagnostics AB generate to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Devyser Diagnostics AB Cash Flow-to-Debt Ratio (2018–2025)
Historical debt coverage capacity for Devyser Diagnostics AB across 8 annual periods. Also explore net asset growth rate of Devyser Diagnostics AB to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Devyser Diagnostics AB (2018–2025)
Year-by-year debt coverage analysis for Devyser Diagnostics AB. For market capitalisation and broader financial context, see Devyser Diagnostics AB (DVYSR) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.07x | Skr8.20 Million | Skr115.40 Million | ▲ +118.9% |
| 2024 | -0.38x | Skr-46.80 Million | Skr124.80 Million | ▲ +32.7% |
| 2023 | -0.56x | Skr-69.70 Million | Skr125.00 Million | ▲ +4.7% |
| 2022 | -0.59x | Skr-40.50 Million | Skr69.19 Million | ▼ -42.7% |
| 2021 | -0.41x | Skr-16.48 Million | Skr40.18 Million | ▼ -2951.1% |
| 2020 | 0.01x | Skr627.00K | Skr43.58 Million | ▼ -96.4% |
| 2019 | 0.40x | Skr14.63 Million | Skr36.69 Million | ▲ +20.9% |
| 2018 | 0.33x | Skr6.02 Million | Skr18.25 Million | — |